IIPR Quick Summary (as of July 1, 2026): Innovative Industrial Properties (NYSE: IIPR) is the US cannabis industry's hidden landlord — 12.3% dividend yield at a $62.01 share price, $7.60 annual dividend. The dividend is not cleanly covered: payout exceeds 100% of AFFO. What keeps it going: a fortress balance sheet with Net-Debt/EBITDA of just ~1.4x. Marco's verdict: paid risk — hold, no new purchases near the 52-week high.
Is IIPR's 12.3% dividend actually covered?
No — at least not cleanly. Adjusted funds from operations (AFFO) for 2025 came in at approximately $7.24 per share while the annual dividend sits at $7.60. Payout ratio: above 100%. That is the uncomfortable truth many investors miss by staring at the yield number alone. At the same time, IIPR carries one of the strongest balance sheets in the REIT sector. Which factor wins out — that is exactly what we examine here. Not investment advice.
Published: July 1, 2026 · Price data as of: July 1, 2026 · Disclosure: This article is for informational purposes only, not investment advice. Marco holds IIPR personally (Scalable Capital, 10 shares). All figures without guarantee.
Before anything else, you should know where I stand: I own IIPR myself. Ten shares through Scalable Capital, entered in December 2024 at an average of roughly EUR 58.13 per share. Today the position sits at around EUR 54.28 — down about 7%, roughly EUR 43 on paper. I say that openly.
A curious detail worth sharing: in US dollar terms, IIPR is trading near its 52-week high — recovered from $44 to around $63. Yet as a euro-based investor I am still slightly negative. The reason is straightforward: the euro strengthened considerably against the dollar over this period. My loss is almost entirely currency, not the underlying stock. I do not minimize it.
| Number of shares | 10 |
| Average cost basis | EUR 58.13 / share |
| Current price (EUR) | EUR 54.28 — −7.4% (−EUR 43.46) |
| NYSE price (USD) | ~$63 — near 52-week high |
| Yield on Cost (YOC) | ~11.5% ($7.60 annual div. on ~$66 cost basis) |
| Dividends received (gross) | ~EUR 78.96 (6 payments since Dec 2024) |
| Dividends received (net) | ~EUR 63.47 |
Source: Parqet / Scalable Capital. Price data July 1, 2026. FX effect explains EUR loss despite USD recovery. No total portfolio disclosure.
The math tells an interesting story: my paper loss is roughly EUR 43, but I have already collected about EUR 79 in gross dividends. The dividend has more than offset the unrealised loss. In total, the position is in profit despite negative price performance. That is exactly why I now run an honest stress test: does this dividend hold, or is a cut coming?
Tool: Yield-on-Cost Calculator — calculate your personal dividend return on your cost basis, free & instant.
Without understanding the business model, neither the 12% yield nor the risk makes sense. Innovative Industrial Properties is a REIT — but a highly specialised one. The company owns cannabis cultivation and production facilities across the US: greenhouses, indoor grow operations, processing plants. Approximately 112 properties across 19 states, no single state exceeding 15% of rents.
The key point: cannabis remains federally illegal in the United States. Federally regulated banks are largely prohibited from financing cannabis companies. An entire, billion-dollar, legal industry — cut off from the normal banking system. IIPR stepped directly into that gap.
The mechanism is called sale-leaseback: IIPR buys a facility from an operator — the operator receives capital — and then leases the property straight back. Under very long contracts (average remaining term ~13.7 years) as a triple-net-lease: tenants pay rent plus taxes, insurance, and maintenance. IIPR essentially collects only the net rent.
At its core, IIPR is not a conventional landlord but a specialised financier in a real estate wrapper. The double-digit yield is the price the market pays for a risk that regulated banks cannot legally take on. High yield is never free.
To understand why IIPR yields 12% instead of 5%, you need two facts. At end-2024, PharmaCann was the largest tenant — 17% of total rental income concentrated in a single company. In March 2025, PharmaCann stopped paying rent on nine of eleven properties.
IIPR actively worked through the problem: reclaimed an Illinois facility, drew $1.3 million from an Ohio court escrow holding withheld rents, and cut PharmaCann's share of revenues from 17% down to approximately 9.9%. The worst is behind them — but a meaningful chunk of rental income is gone.
| Metric | Value |
|---|---|
| Rental revenues 2024 | $308.5 million |
| Rental revenues 2025 | $266.0 million |
| Decline | −13.8% — direct PharmaCann default impact |
| PharmaCann share end-2024 | 17% of rental income |
| PharmaCann share end-2025 | 9.9% (roughly halved) |
| Total properties | ~112 across 19 states |
Sources: IIPR Investor Relations, SEC 10-K 2025, FMP (as of July 1, 2026).
And it is not only PharmaCann. The entire US cannabis sector is under structural pressure: oversupply, falling product prices, crushing tax burdens, and no federal reform in sight. As long as that holds, tenants will remain structurally cash-constrained.
For a REIT, the relevant metric is not reported earnings but AFFO (Adjusted Funds From Operations) — the cash actually available for distribution.
This is the honest, uncomfortable reality: the dividend is currently not cleanly covered. Anyone who ignores this and simply stares at the 12% has not understood the business model.
For historical context: IIPR was once a relentless dividend growth story. The quarterly dividend was $0.15 in 2017 — today it is $1.90. But that growth has been frozen since Q2 2024 — eight consecutive flat quarters. The growth story is over. The only question that matters now: does the plateau hold, or does a cut come?
Here is the surprisingly strong counterargument. At most companies, a payout above 100% is a reliable cut signal. At IIPR, there is one reason the dividend still stands — and it lies in the balance sheet.
| Balance Sheet Metric | IIPR | Typical REIT Peers |
|---|---|---|
| Net-Debt / EBITDA | ~1.4x | 5–6x |
| Debt / Gross Assets | 14% | Covenant allows 60% |
| Interest Coverage | 10.4x | — |
| Unencumbered assets | >$2 billion | — |
| Bond maturing (2026) | ~$290M (refinanceable) | — |
Sources: IIPR Investor Relations, FMP (as of July 1, 2026).
One of the least-leveraged REITs in existence — that is the real strength here. IIPR can bridge the gap between distributions and cash flow for a considerable period because it carries almost no debt and owns over $2 billion in unencumbered property. That is the airbag.
The stock trades at around $63, near its 52-week high. It has recovered strongly from the $44 low in spring 2025. The market is already pricing in some of the stabilisation story.
Two catalysts make this bet interesting:
REITs are valued on P/AFFO (price to adjusted funds from operations), not P/E. IIPR trades at roughly 8–9x P/AFFO. Standard net-lease REITs like Realty Income trade at 12–16x. IIPR is optically much cheaper — but for good reason. The discount is the cannabis risk premium, not a bargain-bin opportunity.
Tenants stable, AFFO recovers above $7.50+
Reform speculation (rescheduling / SAFE Banking) gets priced in. Multiple re-rates toward 11x P/AFFO.
Near current level ($62.01)
Crisis worked through, no growth, dividend narrowly maintained. Status quo persists.
Back toward prior lows
Another major tenant defaults, AFFO falls further, dividend is cut.
Not a price forecast — scenario bandwidth based on script analysis and FMP data. No investment advice.
Compare: Realty Income (O) Analysis — the classic net-lease REIT with covered monthly dividend as a direct contrast to IIPR. Also: MPW REIT 2026 for healthcare REIT context.
What I am concretely doing:
For investors seeking a classic net-lease REIT with a covered dividend: Realty Income (O) is the direct comparison. IIPR is a risk class of its own — and every investor should understand that before entering.
For AFFO forecasts, fair value models and dividend safety checks on IIPR, Realty Income and peers, I use InvestingPro. Use my link for a 15% community discount.
Get 15% Community Discount →Advertisement — affiliate link at no extra cost to you.
What is your yield on cost if you bought IIPR at a different price? The Yield-on-Cost Calculator shows you instantly — free.
Open YOC Calculator →
Not investment advice. All data without guarantee. Marco holds IIPR personally and is therefore not neutral. Please conduct your own due diligence before investing.
Related: Best Dividend Stocks 2026 — full overview · High-Yield Stocks Hub
